Banga Ajay K
Mercer University, College of Pharmacy and Health Sciences, Department of Pharmaceutical Sciences, Atlanta, GA 30341, USA.
Expert Opin Drug Deliv. 2009 Apr;6(4):343-54. doi: 10.1517/17425240902841935.
Microporation involves the creation of micron-sized micropores or microchannels in the skin which can then allow the transport of water soluble molecules and macromolecules. Technologies which can create these microchannels in the skin include mechanical microneedles, thermal or radiofrequency ablation and laser ablation. These technologies will open a new frontier for the delivery of biopharmaceuticals, as these hydrophilic macromolecules cannot be delivered via the skin passively. Companies which are developing these technologies are discussed, along with potential hurdles to commercialization related to the elasticity of skin, immunogenicity issues, pore closure kinetics, or microneedle material and geometries. In spite of the obstacles, these technologies look very promising and are likely to revolutionize transdermal drug delivery in the near future. Bioavailability considerations and the potential use of inexpensive coated microneedles for mass immunizations are also discussed.
微穿孔涉及在皮肤上创建微米级的微孔或微通道,然后这些微孔或微通道可允许水溶性分子和大分子通过。能够在皮肤上创建这些微通道的技术包括机械微针、热消融或射频消融以及激光消融。这些技术将为生物制药的递送开辟一个新的领域,因为这些亲水性大分子无法通过皮肤被动递送。文中讨论了正在开发这些技术的公司,以及与皮肤弹性、免疫原性问题、孔闭合动力学或微针材料和几何形状相关的商业化潜在障碍。尽管存在这些障碍,但这些技术看起来非常有前景,并且很可能在不久的将来彻底改变透皮给药方式。文中还讨论了生物利用度方面的考虑因素以及使用廉价包衣微针进行大规模免疫接种的潜在用途。